Related Experiment Video
Updated: May 27, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Sean Doherty1, Sebastian Hernandez1, Rishi Rikhi2
1Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157 USA.
Lipoprotein(a) [Lp(a)] is a significant, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis (CAVS). Guidelines now recommend Lp(a) testing for primary prevention in all adults.
Area of Science:
- Cardiology
- Genetics
- Lipidology
Background:
- Lipoprotein(a) [Lp(a)] is an atherogenic molecule similar to LDL-C.
- Approximately 20% of the global population has elevated Lp(a) levels, primarily due to genetic factors (~90%).
- Lp(a) possesses proatherogenic, proinflammatory, and antifibrinolytic properties.
Purpose of the Study:
- To review the evidence supporting Lipoprotein(a) [Lp(a)] as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD).
- To summarize the role of Lp(a) in the development of calcific aortic valve stenosis (CAVS).
Main Methods:
- Review of epidemiological data.
- Analysis of genome-wide association studies.
- Examination of Mendelian randomization studies and meta-analyses.
Main Results:
- Strong associations exist between Lp(a) levels and ASCVD and CAVS.
- Emerging data suggest links between Lp(a) and ischemic stroke, peripheral arterial disease, and heart failure, though less robust.
- Multiple lines of evidence confirm Lp(a) as a causal risk factor for ASCVD and CAVS.
Conclusions:
- Current guidelines from major cardiology and lipid associations recommend universal Lp(a) testing for primary ASCVD prevention.
- Further research into Lp(a)-targeted therapies is crucial for understanding its causal role in cardiovascular disease.
- Lp(a) is a validated, genetically influenced risk factor for ASCVD and CAVS.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

